Past CureTalks
Targeting Stem Cells in Multiple Myeloma for Improved Outcomes
Multiple myeloma remains incurable despite improved remissions with novel agents. Relapse eventually occurs in the form of drug-resistant disease that carries a dismal prognosis. Relapse is dependent on stem cell functions. We are talking to Dr. William Matsui of Johns…
Understanding the Medical and Legal Aspects of Surrogacy – An Option in Infertility
Surrogacy is a method of assisted reproduction for people who are unable to conceive due to medical complications or other reasons. It is an agreement where a woman agrees to carry a pregnancy for a couple or a person, who…
Dr. Carl June’s CAR-T Cell Journey and the Cancer Treatment Revolution
FDA approval of the breakthrough CAR-T cell therapy for cancer brings the first approved gene therapy treatment to the United States. It reprograms the body's own immune system to recognize and kill cancer cells. The therapy initially called CAR-T cell…
Demystifying Stem Cell Transplant for Multiple Myeloma Treatment
In 2017 stem cell transplants remains a key option for treatment of eligible multiple myeloma patients, and in majority of patients it is done as a part of frontline therapy. Research shows that stem cell transplants significantly increases the amount of…
Webinar: Climbing Mount Kilimanjaro for the MMRF with Myeloma Patient Advocate Matt Goldman
In February 2017, along with 5 other patients and 10 individuals who have had their lives impacted by myeloma, Matt Goldman climbed Mt. Kilimanjaro in Tanzania, Africa. They were raising funds for Multiple Myeloma Research Foundation (MMRF), which is a…